NCT02988271View on ClinicalTrials.gov

Meditation Therapy in Improving Anxiety and Depression in Cancer Patients With Psychosocial Distress

NAActive, not recruitingINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

April 11, 2019

Primary Completion Date

February 28, 2026

Study Completion Date

February 28, 2026

Conditions
AnxietyDepressionMalignant Neoplasm
Interventions
OTHER

Interview

Participate in interview

PROCEDURE

Meditation Therapy

Complete meditation therapy

PROCEDURE

Quality-of-Life Assessment

Complete questionnaires

PROCEDURE

Supportive Care

Receive supportive care

Trial Locations (1)

77030

M D Anderson Cancer Center, Houston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

M.D. Anderson Cancer Center

OTHER

NCT02988271 - Meditation Therapy in Improving Anxiety and Depression in Cancer Patients With Psychosocial Distress | Biotech Hunter | Biotech Hunter